Anticipating the impact of the continuously rising Omicron variant, 125 regencies/cities aggressively conducted testing, exceeding the national average weekly percentage of people tested. Data from the week of November 13, 2022, shows a national average testing rate of 7.54 percent. This testing achievement data is calculated based on the number of people tested compared to each region's weekly target, subsequently reported to the Ministry of Health.
The top five, starting with the highest weekly percentage of people tested, are Semarang (154.75%), Metro City (96%), Badung (84.04%), Keerom (71.43%), and Pakpak Bharat (67.86%).
Semarang ranks first, with a weekly testing percentage of 154.75 percent. The latest positive rate is 2.62 percent. The positive rate in this region increased compared to the previous week.
Next is Metro City, with a population of 174,260. In efforts to combat the COVID-19 pandemic, the weekly testing percentage reached 96 percent. The positive rate in this region is 3.57 percent, also higher than the previous week.
Badung recorded 84.04 percent testing, Keerom 71.43 percent, and Pakpak Bharat 67.86 percent.
Anticipating the impact of Omicron in various regions, based on a national COVID-19 data recapitulation, 170 regencies/cities in Indonesia actively reported a higher weekly percentage of people tested compared to the previous week. Meanwhile, 145 other regencies/cities recorded a lower weekly testing percentage compared to the previous week.
Some of the regions outside Java with the highest weekly testing percentage ratios include Metro City, Badung, and Keerom, with weekly testing percentages of 96 percent, 84.04 percent, and 71.43 percent, respectively.
Although COVID-19 transmission has decreased in some areas, the government urges everyone to continue reducing COVID-19 transmission by consistently wearing masks, maintaining physical distance, and frequently washing hands with soap and running water. Avoiding crowds and reducing mobility also contribute to suppressing the spread of the coronavirus.